The trademark application Omnigen was filed by NuVision Biotherapies Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on February 2, 2017, and it was registered by office on May 14, 2017 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 10, 2020. Appointment and Replacement of representative of the trademark registration was recorded on July 10, 2023. Appointment and Replacement of representative of the trademark registration was recorded on November 2, 2023. Appointment and Replacement of representative of the trademark registration was recorded on December 21, 2023.
Goods And Services
The mark was filed in class 5 with following description of goods:
Human allograft tissue
Tissue-regenerative pharmaceutical preparations
Implants comprising living tissue
Biological tissue cultures for medical purposes
Implants for guided tissue regeneration
Tissues impregnated with pharmaceutical lotions
Surgical implants comprised of living tissues
Implantable materials for use in guided tissue regeneration
Surgical implants grown from stem cells [living tissues]
Implantable textile material to encourage the growth of tissue
Biological preparations for medical purposes
Denatured biological tissue
Denatured human tissue
Implants comprising of dead tissue
Denatured amniotic tissue
Human amniotic tissue
Dead human tissue
Surgical implants comprised of denatured human tissue
Implantable tissue derived from human amniotic fluid cells.
The mark was filed in class 10 with following description of goods: